{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:55:43Z","timestamp":1776128143427,"version":"3.50.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1097\/md.0000000000008159","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T16:21:01Z","timestamp":1506529261000},"page":"e8159","source":"Crossref","is-referenced-by-count":6,"title":["Methimazole-induced liver injury overshadowed by methylprednisolone pulse therapy"],"prefix":"10.1097","volume":"96","author":[{"given":"Silvijus","family":"Abramavicius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dzilda","family":"Velickiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmundas","family":"Kadusevicius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-55-20210309","doi-asserted-by":"crossref","first-page":"656","DOI":"10.5812\/kowsar.1735143X.641","article-title":"Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature","volume":"11","author":"Gutkowski","year":"2011","journal-title":"Hepat Mon"},{"key":"R2-55-20210309","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/thy.2000.10.521","article-title":"Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease","volume":"10","author":"Weissel","year":"2000","journal-title":"Thyroid"},{"key":"R3-55-20210309","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ajg.2014.131","article-title":"ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury","volume":"109","author":"Chalasani","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R4-55-20210309","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4254\/wjh.v9.i10.491","article-title":"Drug-induced liver injury: do we know everything?","volume":"9","author":"Alempijevic","year":"2017","journal-title":"World J Hepatol"},{"key":"R5-55-20210309","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12072-017-9793-2","article-title":"CSH guidelines for the diagnosis and treatment of drug-induced liver injury","volume":"11","author":"Yu","year":"2017","journal-title":"Hepatol Int"},{"key":"R6-55-20210309","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R7-55-20210309","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.3748\/wjg.14.6774","article-title":"Practical guidelines for diagnosis and early management of drug-induced liver injury","volume":"14","author":"Tajiri","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R9-55-20210309","first-page":"1","article-title":"An overview on the proposed mechanisms of antithyroid drugs-induced liver injury","volume":"5","author":"Heidari","year":"2015","journal-title":"Adv Pharm Bull"},{"key":"R10-55-20210309","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.1968.03150080067019","article-title":"Hepatitis from methimazole during adrenal steroid therapy for malignant exophthalmos","volume":"206","author":"Becker","year":"1968","journal-title":"JAMA"},{"key":"R11-55-20210309","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12020-009-9305-9","article-title":"Steroids for the treatment of methimazole-induced severe cholestatic jaundice in a 74-year-old woman with type 2 diabetes","volume":"37","author":"Zhang","year":"2010","journal-title":"Endocrine"},{"key":"R12-55-20210309","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2265.2012.04365.x","article-title":"Hepatotoxicity and cutaneous reactions after antithyroid drug administration","volume":"77","author":"Otsuka","year":"2012","journal-title":"Clin Endocrinol (Oxf"},{"key":"R13-55-20210309","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000180054","article-title":"Hepatotoxicity from antithyroid drugs","volume":"21","author":"Vitug","year":"1985","journal-title":"Horm Res"},{"key":"R15-55-20210309","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"R17-55-20210309","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3904\/kjim.1990.5.1.69","article-title":"A case of methimazole-induced acute hepatic failure in a patient with chronic hepatitis B carrier","volume":"5","author":"Kang","year":"1990","journal-title":"Korean J Intern Med"},{"key":"R18-55-20210309","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.18632\/oncotarget.6144","article-title":"Methimazole-induced cholestatic hepatitis: two cases report and literature review","volume":"7","author":"Zou","year":"2016","journal-title":"Oncotarget"},{"key":"R19-55-20210309","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/thy.2014.0350","article-title":"Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China","volume":"25","author":"Yang","year":"2015","journal-title":"Thyroid"},{"key":"R20-55-20210309","doi-asserted-by":"crossref","first-page":"835979","DOI":"10.1155\/2015\/835979","article-title":"Liver dysfunction associated with intravenous methylprednisolone pulse therapy in patients with Graves\u2019 orbitopathy","volume":"2015","author":"Eguchi","year":"2015","journal-title":"Int J Endocrinol"},{"key":"R21-55-20210309","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00228-013-1632-3","article-title":"Methylprednisolone-induced hepatotoxicity: experiences from global adverse drug reaction surveillance","volume":"70","author":"Caster","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"R22-55-20210309","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/thy.2006.0267","article-title":"Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves\u2019 ophthalmopathy","volume":"17","author":"Le Moli","year":"2007","journal-title":"Thyroid"},{"key":"R23-55-20210309","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-14-0712","article-title":"Intravenous glucocorticoid therapy for Graves\u2019 ophthalmopathy and acute liver damage: an epidemiological study","volume":"172","author":"Sisti","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"R24-55-20210309","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1055\/s-2007-1024398","article-title":"[Fatal liver failure after corticosteroid treatment of a hepatitis B virus carrier]","volume":"124","author":"Hammond","year":"1999","journal-title":"Dtsch Med Wochenschr"},{"key":"R25-55-20210309","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2169\/internalmedicine.53.3194","article-title":"Hepatitis C virus (HCV) reactivation caused by steroid therapy for dermatomyositis","volume":"53","author":"Mori","year":"2014","journal-title":"Intern Med"},{"key":"R27-55-20210309","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF00541537","article-title":"Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults","volume":"30","author":"Szefler","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"R28-55-20210309","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1023\/A:1016225423795","article-title":"Effect of corticosteroid binding globulin on the pharmacokinetics of prednisolone in rats","volume":"12","author":"Ko","year":"1995","journal-title":"Pharm Res"},{"key":"R30-55-20210309","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2009.01.013","article-title":"Effects of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects","volume":"84","author":"Koga","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"R31-55-20210309","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3350\/cmh.2014.20.3.237","article-title":"Factors affecting drug-induced liver injury: antithyroid drugs as instances","volume":"20","author":"Heidari","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"R32-55-20210309","first-page":"390","article-title":"Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes","volume":"25","author":"Guo","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"R33-55-20210309","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1124\/dmd.110.037895","article-title":"The tissue-specific toxicity of methimazole in the mouse olfactory mucosa is partly mediated through target-tissue metabolic activation by CYP2A5","volume":"39","author":"Xie","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"R34-55-20210309","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0009-9236(03)00066-3","article-title":"Effects of the neurokinin1 receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone","volume":"74","author":"McCrea","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"R35-55-20210309","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/0091270006287588","article-title":"Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition","volume":"46","author":"Lee","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"R36-55-20210309","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bcpt.12530","article-title":"Variability of voriconazole trough levels in haematological patients: influence of comedications with cytochrome P450(CYP) inhibitors and\/or with CYP inhibitors plus CYP inducers","volume":"118","author":"Cojutti","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R37-55-20210309","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1517\/17425255.2014.878703","article-title":"Cytochrome P450 enzyme regulation by glucocorticoids and consequences in terms of drug interaction","volume":"10","author":"Matoulkov\u00e1","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R38-55-20210309","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jprot.2017.03.007","article-title":"Functional proteomic analysis of corticosteroid pharmacodynamics in rat liver: Relationship to hepatic stress, signaling, energy regulation, and drug metabolism","volume":"160","author":"Ayyar","year":"2017","journal-title":"J Proteomics"},{"key":"R39-55-20210309","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0009-9236(98)90066-2","article-title":"Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole*","volume":"64","author":"Varis","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"R40-55-20210309","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/clpt.1986.114","article-title":"Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion","volume":"39","author":"Glynn","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"R41-55-20210309","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s002280100340","article-title":"Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo","volume":"57","author":"Villikka","year":"2001","journal-title":"European Journal of Clinical Pharmacology"},{"key":"R42-55-20210309","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1152\/physiolgenomics.00242.2006","article-title":"Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens","volume":"30","author":"Almon","year":"2007","journal-title":"Physiological Genomics"},{"key":"R43-55-20210309","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/faat.1997.2307","article-title":"Effect of methimazole, an FMO substrate and competitive inhibitor, on the neurotoxicity of 3,3\u2019-iminodipropionitrile in male rats","volume":"37","author":"Nace","year":"1997","journal-title":"Fundam Appl Toxicol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:34:55Z","timestamp":1620959695000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201709290-00055"}},"subtitle":["Case report"],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":38,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008159","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}